Education
About Us
Working with TipRanks
Follow Us
Daily Stock Ratings & Price Targets
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$0.65→C$0.7 | ― | 20.50% | Reiterated | ||||
 | Bank Of Nova Scotia | HOLD C$97 | ― | -7.20% | Reiterated | Analysts Offer Insights on Financial Companies: Bank Of Nova Scotia (NYSE: BNS), BOC Hong Kong (Holdings) (Other OTC: BNKHF) and CME Group (NASDAQ: CME) | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$5.5 | ― | 2.00% | Upgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$24 | ― | 28.20% | Initiated | ||||
| GFL Environmental | BUY C$89.42 | ― | -0.90% | Reiterated | GFL Environmental: Strategic Moves and Growth Prospects Justify Buy Rating | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$6 | ― | 34.70% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$3 | ― | 10.30% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$65 | ― | 14.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$20 | ― | 14.60% | Reiterated | ||||
| Hydreight Technologies Inc | BUY C$8.5 | ― | -13.00% | Reiterated | Hydreight Technologies Inc: A Compelling Buy Amidst Growth Potential and Strategic Expansion | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$18.5 | ― | 24.70% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$77→C$89.5 | ― | 49.90% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$54→C$82 | ― | 12.70% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$7.75 | ― | 45.90% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$3.75 | ― | 49.90% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$98→C$100 | ― | 14.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$20→C$22 | ― | 15.70% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$69.86→C$74.05 | ― | 9.30% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL C$34→C$35 | ― | 9.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$1.68→C$1.96 | ― | 41.80% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$22.34→C$25.74 | ― | 6.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD | ― | 8.00% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$24→C$29 | ― | 18.60% | Upgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$208→C$153 | ― | 4.20% | Downgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$27→C$29 | ― | 15.10% | Reiterated | ||||
| Curaleaf Holdings | BUY C$4.5 | ― | -9.40% | Upgraded | Curaleaf upgraded to Outperform from Sector Perform at ATB Capital | |||
| Cresco Labs | BUY C$2.5 | ― | -9.40% | Upgraded | Cresco Labs upgraded to Outperform from Sector Perform at ATB Capital | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$0.5 | ― | 50.90% | Reiterated | ||||
| NowVertical Group Inc | BUY C$0.55 | ― | -18.30% | Initiated | NowVertical initiated with a Buy at Cormark | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$4 | ― | 27.40% | Initiated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$58→C$77 | ― | 14.90% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$176.05 | ― | 11.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$9.25 | ― | 5.00% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$251.5→C$265.47 | ― | 16.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$162.08→C$164.87 | ― | 16.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$43.31→C$46.11 | ― | 16.80% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY | ― | 21.30% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$16.77 | ― | 15.70% | Upgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$8→C$9 | ― | 21.10% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$68→C$70 | ― | 21.10% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$38→C$33 | ― | 21.10% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD C$14→C$13 | ― | 7.60% | Upgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$0.3 | ― | 48.50% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$2.1→C$2.2 | ― | 41.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$36 | ― | 3.00% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$0.4 | ― | 48.50% | Reiterated | ||||
 | Allied Properties Real Estate Investment Trust | HOLD C$14.75→C$14 | ― | -1.20% | Upgraded | Allied Properties upgraded to Market Perform from Underperform at Raymond James | |||
 | Cardiol Therapeutics | BUY C$12.57 | ― | -0.30% | Reiterated | Cardiol Therapeutics: Strong Buy Rating Backed by Promising CardiolRx Trial Results and Strategic Growth Potential | |||
 | MustGrow Biologics | HOLD | ― | -1.50% | Reiterated | Analysts Offer Insights on Materials Companies: Bluescope Steel (Other OTC: BLSFF), MustGrow Biologics (Other OTC: MGROF) and IGO (Other OTC: IPGDF) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY C$279.44 | ― | 11.20% | Reiterated |
Rows:
